These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21276737)

  • 1. Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavage.
    Verleden SE; Vos R; Mertens V; Willems-Widyastuti A; De Vleeschauwer SI; Dupont LJ; Verleden GM; Van Raemdonck DE; Vanaudenaerde BM
    J Heart Lung Transplant; 2011 Jun; 30(6):667-73. PubMed ID: 21276737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
    Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
    Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
    Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
    Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
    Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
    Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together?
    Vos R; Blondeau K; Vanaudenaerde BM; Mertens V; Van Raemdonck DE; Sifrim D; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2008 Aug; 27(8):843-9. PubMed ID: 18656796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients.
    Verleden SE; Vandooren J; Vos R; Willems S; Dupont LJ; Verleden GM; Van Raemdonck DE; Opdenakker G; Vanaudenaerde BM
    Transpl Immunol; 2011 Sep; 25(2-3):159-62. PubMed ID: 21740970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
    Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD
    J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased net gelatinase but not serine protease activity in bronchiolitis obliterans syndrome.
    Riise GC; Ericson P; Bozinovski S; Yoshihara S; Anderson GP; Lindén A
    J Heart Lung Transplant; 2010 Jul; 29(7):800-7. PubMed ID: 20417130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
    Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction.
    de Jong PA; Vos R; Verleden GM; Vanaudenaerde BM; Verschakelen JA
    Eur Radiol; 2011 Dec; 21(12):2466-74. PubMed ID: 21792614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplant Proc; 2009 Mar; 41(2):595-8. PubMed ID: 19328934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival determinants in lung transplant patients with chronic allograft dysfunction.
    Verleden GM; Vos R; Verleden SE; De Wever W; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transplantation; 2011 Sep; 92(6):703-8. PubMed ID: 21836537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.